Objectives: Murine models of critical illness are commonly used to test new therapeutic interventions. However, these interventions are often administered at fixed time intervals after the insult, perhaps ignoring the inherent variability in magnitude and temporality of the host response. We propose to use wireless biotelemetry monitoring to define and validate criteria for acute deterioration and generate a physiology-based murine cecal ligation and puncture model that is more similar to the conduct of human trials of sepsis. Design: Laboratory and animal research. Setting: University basic science laboratory. Subjects: Male C57BL/6 mice. Interventions: Mice underwent cecal ligation and puncture, and an HD-X11 wireless telemetry monitor (Data Sciences International) was implanted that enabled continuous, real-time measurement of heart rate, core temperature, and mobility. We performed a population-based analysis to determine threshold criteria that met face validity for acute physiologic deterioration. We assessed construct validity by temporally matching mice that met these acute physiologic deterioration thresholds with mice that had not yet met deterioration threshold. We analyzed matched blood samples for blood gas, inflammatory cytokine concentration, cystatin C, and alanine aminotransferase. Measurements and Main Results: We observed that a 10% reduction in both heart rate and temperature sustained for greater than or equal to 10 minutes defined acute physiologic deterioration. There was significant variability in the time to reach acute deterioration threshold across mice, ranging from 339 to 529 minutes after cecal ligation and puncture. We found adequate construct validity, as mice that met criteria for acute deterioration had significantly worse shock, systemic inflammation (elevated tumor necrosis factor-α, p = 0.003; interleukin-6, p = 0.01; interleukin-10, p = 0.005), and acute kidney injury when compared with mice that had not yet met acute deterioration criteria. Conclusions: We defined a murine threshold for acute physiologic deterioration after cecal ligation and puncture that has adequate face and construct validity. This model may enable a more physiology-based model for evaluation of novel therapeutics in critical illness. (Crit Care Med 2016; 44:e420-e431) 
model of host defense and barrier breakdown incorporates several components to create a dynamic and complex model of sepsis: tissue trauma from the surgical procedure, tissue necrosis from the cecal ligation and devascularization, and polymicrobial infectious insult from cecal puncture(s) (11) . Although relatively simple, CLP has significant variability due to puncture size and quantity, fasting state or diet of the animals, anesthetic differences, extruding different amounts of stool from the cecum after puncture, time of day, and interoperator variability in incision size and surgical technique (8, 12) . Historically, this is overcome by increasing sample size. These issues often result in a heterogeneous population at varying stages of the host response to sepsis (13) .
An ideal animal model of sepsis would incorporate the physiology of the host response to septic insult. To accomplish this goal, we will use novel implantable biotelemetry technology, an emerging technique in small animal studies of sepsis . We hypothesize that implantable biotelemetry will aid in the identification of thresholds for acute physiologic deterioration after CLP that have both face and construct validity. Such a model that incorporates real-time assessment of physiology may allow the design of animal trials more relevant to the physiologic inclusion criteria of human clinical trials in sepsis, as treatments could be then administered at the precise point of physiologic deterioration.
MATERIALS AND METHODS

Ethics Statement
All experiments were performed in accordance with the National Institutes of Health guidelines under protocols approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh (protocol no. 13021581).
Mice
Male C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) aged 8 to 12 weeks (mass, 25-30 g) were used for all experiments. Mice were housed in specific pathogen-free rooms under 12-hour light/12-hour dark conditions cycled on at 7:00 am and off at 7:00 pm. Ambient temperature in animal housing areas ranged from 21°C to 24°C. Animals were given ad libitum access to water and LabDiet Prolab Isopro RMH 3000 diet pellets (LabDiet, St. Louis, MO). Experiments were conducted in the morning to control for circadian variations.
Wireless Telemetry Technology
Mice were monitored using DSI HD-X11 implanted wireless telemetry (Data Sciences International, St. Paul, MN). The HD-X11 is a reusable 2.2-g, 1.4-cc wireless telemetry device capable of continuous measurement of one biopotential (e.g., electrocardiogram), systemic blood pressure, core body temperature, and animal activity. Monitors were implanted within the peritoneal cavity according to the manufacturer's instructions. Data collection and analysis were performed by using Ponemah version 5.20 (Data Sciences International).
Cecal Ligation and Puncture
Anesthesia was induced by isoflurane (2-4%) followed by intraperitoneal injection of ketamine (75 mg/kg) and xylazine (6 mg/kg). A 21-gauge, double-puncture CLP was performed as previously published by using a cecal ligation of 1 cm as measured from the cecal tip (9, 10) . Care was taken to avoid occluding the ileocecal junction. A small amount (1 mm) of cecal contents was extruded using gentle pressure after punctures were created. The cecum was then returned to the abdominal cavity and placed in the upper central abdomen.
At the time of laparotomy, skin flaps were raised lateral to the incision on both sides of the abdomen for placement of biopotential leads. The telemetry device was then implanted in the peritoneal cavity as per the manufacturer's instructions. Biopotential leads were brought through the rectus bilaterally, and the fascia was closed with interrupted 4-0 Vicryl suture (Ethicon, Somerville, NJ). Biopotential leads were then tunneled subcutaneously to achieve positioning analogous to Lead II in human electrocardiography. The skin was closed with simple interrupted 4-0 polydioxanone sutures (Ethicon). After completion of the procedure, mice were immediately administered warmed 0.9% normal saline (30 cc/kg subcutaneous), as described in the study by Hubbard et al (8) .
One primary objective was to develop a testable murine model of sepsis more translatable to the sepsis experienced by a person prior to the presentation for or administration of medical care. Thus, no antibiotics were administered during the course of the study. Mice were placed in individual cages, which were situated on a heating pad until the mice righted themselves and had regained independent mobility. All mice received buprenorphine analgesia (0.1 mg/kg SQ Q12H) as per our protocol established in conjunction with University of Pittsburgh Institutional Animal Care and Use Committee guidelines (41) (42) (43) . This dose was not found to produce any cardiac or activity depression. Data acquisition began immediately after an animal exhibited full emergence from anesthesia (i.e., upright and independent mobility and foraging). During the period of monitoring, heart rate (beats/ min), core temperature (degrees celsius), and activity data were acquired every minute. Physiologic monitoring was continued for 24 hours after surgery in initial descriptive groups and up to 7 days in later descriptive cohorts of mice. Sham animals underwent laparotomy and bowel manipulation without CLP, telemetry monitor implantation, and data acquisition for a 24-hour period. At the times indicated, mice were euthanized, and blood samples were obtained by cardiac puncture (right ventricle).
Variability of Mice at Fixed Time Intervals After CLP
To investigate the suspected variability in inflammatory response and organ dysfunction between individual mice at fixed time points, two groups of mice (n = 6 for each group) underwent CLP and were killed at either 6 or 12 hours after surgery. The time points of 6 and 12 hours after CLP were chosen as representative points where investigators have typically elected to test potential therapies (24, 44, 45) . Plasma samples were analyzed for markers of inflammation (tumor necrosis factor [TNF]-α, interleukin [IL]-6, and IL-10) and organ dysfunction (cystatin C).
Definition and Validation of Acute Physiologic Deterioration
We performed a population-based analysis of the descriptive cohort data to identify physiologic (i.e., heart rate and core temperature) thresholds that best classified mice into those that had acutely deteriorated after CLP versus those who had not. Mice were determined to meet a threshold for acute deterioration after experiencing sustained declines in both heart rate and temperature of at least 10% from their peak values. After demonstrating that the newly defined thresholds for deterioration had adequate face validity, we tested construct validity of our "acute deterioration" definition by killing mice at the acute physiologic deterioration threshold, temporally matched to another CLP mouse that had not reached deterioration threshold. We analyzed matched blood samples for markers of inflammation (TNFα, IL-6, and IL-10), organ dysfunction (cystatin C and alanine aminotransferase [ALT] concentrations), and shock (mixed venous blood gas analysis). Quantitative bacterial cultures from blood and peritoneal lavage fluid were also compared between CLP mice at the defined deterioration threshold and those that had not experienced physiologic decline. 
Bacterial Culture
At the time of killing the mice after CLP, the peritoneal cavity was irrigated with 1 mL of sterile phosphate-buffered saline solution, and samples were collected in a sterile manner. Heparinized whole blood was also obtained by cardiac puncture using sterile technique. Peritoneal lavage and serum samples were serially diluted, plated on 5% sheep blood agar (Teknova, Hollister, CA), and incubated at 37°C overnight. Colony-forming units were quantified by manual counting.
Inflammatory Cytokine and Organ Dysfunction Analysis
Heparinized blood samples were centrifuged at 2,000g for 15 minutes, serum was collected, and samples were stored at -80°C for future analysis. Peritoneal fluid samples remaining after plating bacterial cultures were stored at -80°C for future analysis. Thawed samples then underwent quantitative analysis for markers of inflammation (IL-6, TNFα, and IL-10) and renal failure (cystatin C) using enzyme immunoassay kits (R&D Systems, Minneapolis, MN). Cystatin C has emerged as a more precise marker of glomerular filtration rate and has been validated in murine and human studies (46) (47) (48) . Liver injury was quantified by measuring ALT by using a Heska DRI-CHEM 4000 automated dry chemistry analyzer (Heska, Loveland, CO).
Blood Gas Parameters of Shock
Heparinized blood collected at the time of animal killing immediately underwent venous blood gas analysis with the use of an i-STAT portable handheld device (Abbott, Princeton, NJ).
Statistical Analysis
We analyzed continuous data by using nonparametric rank-sum and categorical data by using chi-square analyses. A p value less than 0.05 was considered significant.
RESULTS
Baseline Physiology Parameters and Biomarker Analysis
We observed an early bradycardia in the initial postoperative and postimplantation phases ( Fig. 1A) , with gradual recovery over the first 2-3 hours (median time, 131 min; range, 56-301 min) to a normal range: 500-700 beats/min (49) . We observed a corresponding mild hypothermia after surgery ( Fig. 1B) , with core temperature recovering to normal values, typically after recovery of bradycardia. Early hypothermia after CLP due to ketamine/xylazine anesthesia has been previously described in the literature (29) . We have listed baseline values for biomarkers of inflammation and organ dysfunction in C57BL/6 male mice not undergoing CLP, both with and without telemetry monitor implantation, in Table 1 .
Variability of the Murine Response to Sepsis
Our clinical correlate was the early (initial 24 hr) period of sepsis that a person may experience prior to receiving medical care. Thus, we initially studied and characterized the murine physiology during the first 24 hours after CLP. We observed considerable heterogeneity in the physiologic and thermoregulatory responses to sepsis among mice subjected to CLP (Fig. 2, A and B) . Five of 16 mice (31.3%) died in the initial 24-hour period. Five mice (31.3%) exhibited minimal physiologic disturbance after CLP, with heart rate and core temperature values remaining near normal. The remaining six mice (37.5%) exhibited intermediate (moderate to severe) levels of physiologic derangement. At the traditional 6-and 12-hour time points of evaluation after CLP, we observed a wide range of physiologic responses with some mice exhibiting little physiologic alterations and others being nearly moribund (Fig. 2, A and B) .
Reports in the literature have described biologic differences between mice that die "early" and those dying "later" after CLP (50) . Thus, we further characterized the physiology of mice that survived the initial 24 hours of CLP sepsis. We observed considerable heterogeneity in each mouse's physiologic trajectory ( Fig. 3, A and B) . All mice ultimately reached their threshold physiologic deterioration threshold, and 83% died during the 7-day period of observation ( Fig. 4) . However, although mice experienced physiologic decline at widely varying times, the sharp decline in core temperature and bradycardia was a conserved event preceding death.
To better and more objectively characterize the heterogeneity in the biologic response to sepsis, we sampled mice at two time points commonly used for testing interventions in murine CLP models: 6 and 12 hours. As shown in Figure 5 , we found widely varying inflammatory responses of mice at both 6 and 12 hours after CLP. For example, at the 6-hour time point after CLP, IL-6 ranged from 15,063 to 49,220 pg/mL (Fig. 5B) . In addition, a wide range of magnitudes of acute kidney injury was also observed, as cystatin C concentrations 6 hours after CLP ranged from 390 to 879 ng/mL ( Fig. 5D ).
Defining Thresholds for Acute Deterioration
Noting the temporal heterogeneity in each animal's physiologic response to CLP, we explored whether the biotelemetry parameters could be modeled to identify a similar state in the host response to sepsis for each animal, independent of time after CLP. We investigated longitudinal physiology curves justified to either the time of death or the time of last observation (1,440 min post-CLP). We noted that for those mice dying prior to 1,440 minutes, the heart rate and temperature trajectory were nearly superimposable (Fig. 6, A  and B) . However, individual mice reached a point of acute physiologic deterioration at varying times after CLP, ranging from 356 to 1,344 minutes. Scanning the population of temperature and heart rate trajectories, we defined thresholds for acute deterioration that had adequate face validity-a 10% drop in heart rate from the observed maximum combined with a fall in core temperature (10% of the difference between maximum temperature and 25°C) that were sustained for at least 10 minutes. As aforementioned, several animal studies highlight that the biology of late deaths is different from that of deaths occurring early (< 24 hr) after CLP (50) . They further note the resultant limitations imposed by these biologic differences on the generalized use of biomarker prognostication (51) . By contrast, we observed in the cohort of mice monitored for 7 days that the heart rate and temperature trajectories, when justified to death, were similar to those of animals dying early (Fig. 6, C  and D) . Thus, our "acute deterioration threshold" definition appeared similarly applicable to and valid for deaths occurring at later time points.
Construct Validity
We killed mice in matched pairs consisting of one mouse that had met criteria for acute physiologic deterioration and another control CLP mouse that had not met criteria (n = 12 pairs). The average time for mice to meet criteria for acute deterioration after surgery was 433 minutes (range, 340-532 min), which was not different from mean time to killing for matched nonthreshold CLP mice (426 min; range, 347-502 min; p = not significant).
We determined the construct validity of our threshold definitions as representing a different biologic trajectory and measured inflammatory cytokines, blood gas parameters of shock, and markers of kidney and liver dysfunction. Mice that met criteria for acute physiologic deterioration had significantly greater systemic concentrations of TNFα, IL-6, and IL-10 when compared with mice that had not yet met criteria for deterioration after CLP ( Table 2 and Fig. 7) . For example, a mouse at threshold, on average, had an IL-6 concentration of 26,148 pg/mL compared with a matched nonthreshold CLP mouse with a mean IL-6 concentration of 10,424 pg/mL (Fig. 7B) . Similarly, mice that reached the threshold deterioration criteria exhibited significantly worse shock than mice not meeting criteria, as evidenced by worse acidemia and elevated base deficit (Table 2 ). Finally, mice that had met threshold for acute deterioration exhibited higher concentrations of cystatin C in comparison to mice that had not: 600 versus 480 ng/mL, p = 0.09 ( Table 2 and Fig. 7D ). There was no significant difference in ALT as a marker of liver injury ( Table 2) .
Bacterial Clearance
After determining that mice meeting our criteria for acute deterioration showed higher levels of inflammation, shock, and renal dysfunction, we sought to elucidate potential mechanisms for these observed differences. We initially focused on differences in bacterial clearance. As shown in Figure 8 , mice that met the threshold for deterioration had higher bacterial growth in both the peritoneal cavity and in the blood than mice that had not met deterioration threshold.
DISCUSSION
Murine models have long been key to advances in understanding the host-pathogen interaction during sepsis. However, multiple recent studies of novel therapeutics have failed to translate evidence from animal models into meaningful changes in patient outcomes. One potential limitation is that contemporary murine models test interventions at fixed time points, ignoring the inherent temporality of the host response to severe infection. What's more, most human trials use physiology-based enrollment criteria and triggers for intervention. We address this important issue by developing a physiology-and biology-oriented murine model of sepsis that identifies the point of acute physiologic deterioration after CLP using wireless biotelemetry. This model more precisely identifies a similar point in the spectrum of host response to sepsis for each animal, independent of lapsed time after the septic insult. In doing so, our model yields a more homogeneous cohort of testable mice at Critical Care Medicine www.ccmjournal.org e427 a similar physiologic state and accurately excludes mice that do not meet physiologic inclusion criteria; these are fundamental characteristics of the conduct of human sepsis trials.
For more than a decade, there have been calls to develop more clinically relevant animal models in sepsis (52) . Many modifiable features of animal models introduce bias: choice of model and technique (e.g., CLP vs lipopolysaccharide injection, CLP puncture size, and quantity), choice of anesthetic and analgesics, varying fluid resuscitation practices, routine use of antibiotics, and administration of treatments at fixed time intervals. Thus, in the context of time after CLP, there exists considerable heterogeneity in both the magnitude and timing of the murine response to CLP sepsis. Indeed, we observed both mice exhibiting a profound host response to CLP resulting in death within the first 24 hours, as well as, those with only a minor disturbance that approximated normal physiology. These data highlight the inherent limitations imposed when testing treatments at fixed time intervals: animals are being treated at very different points in their biologic response. Figure 6 . Population-based analyses of heart rate and core temperature. A, Heart rate (24 hr). B, Core temperature (24 hr). C, Heart rate (7 d). D, Core temperature (7 d). Longitudinal measurements of heart rate and core temperature for each mouse were zeroed at either time point of death or time point of last observation. Population-based analyses using fractional polynomial methodology were performed to generate means and 95% CIs of longitudinal panel data for the three cohorts: sham control (blue), cecal ligation and puncture (CLP)-dead (red), and CLP-alive (orange). Single data points are represented by individual dots; average slope for each group is plotted with a bold line. Groups separated by color as indicated. bpm = beats/min.
To address these limitations, a considerable amount of investigative work has been conducted using biomarker measurements, such as cytokines, to prognostically stratify severity of illness (51, 53, 54) . In one notable study, IL-6 measured 6 hours post-CLP and dichotomized at 2,000 pg/mL effectively classified animals as nonsurvivors versus survivors, which exhibited mortality rates of approximately 90% versus 30% (53) . The group of predictive cytokines was expanded to also include TNF-α, keratinocyte chemoattractant, macrophage inflammatory protein-2, IL-1 receptor antagonist, TNF soluble receptor I, and TNF soluble receptor II (51) . The investigators further demonstrated that stratification of mice into survivors and nonsurvivors based on cytokine measurements allowed them to select a cohort more appropriate for testing of experimental therapies (54) . However, in this study, a considerable proportion (approximately 30%) of mice categorized as "survivors" based on low IL-6 concentration still progressed to death (53) . Perhaps, this misclassification is one limitation of a single biochemical assessment performed at an early time point after the insult.
By contrast, biotelemetry enables the continuous monitoring of each animal and thus accounts for interanimal variability. It has been used in multiple studies to describe physiologic changes in response to candidate sepsis therapies; however, this differs from using the technology to define physiologic inclusion criteria to test a therapeutic, as performed here (14, 19, 21, 22, 24, 26, 29, 33-35, 38, 39) . In our model, coupling of biotelemetry with a CLP model helped quantify physiologic differences in the murine response to sepsis that were indicative of significant biologic differences, including inflammation and degree of shock and organ dysfunction. We were able to define a physiologic threshold for "acute deterioration" that identified a similar physiologic point of decompensation for each animal, independent of time after insult. Although meeting these criteria did not guarantee that the mouse will have a fatal outcome in the first 24 hours after CLP, it effectively excluded the possibility that the mouse would be a mild or nonresponder to the CLP insult. Indeed, nearly all animals that reached our deterioration threshold died, and all that did not reach threshold survived. These data highlight the accuracy of our technique in predicting the binary outcome of death. Thus, these data facilitate the standardization of experiments and enable the investigator to deliver treatments at specific biologic points along the host-pathogen sepsis response curve. Rather than waiting on biochemical assays, which may take several hours to process before mice can be stratified, we gain the ability to stratify in real time. Furthermore, our model reduces the population variability, producing a model that may be more "sensitive" to identifying therapeutic differences in tested treatment regimens. We propose that our model enables prognostication but does so dynamically and specifically to each animal's unique temporal response.
Several publications have highlighted that mice dying later exhibit variable responses in terms of inflammatory cytokine production compared with mice dying earlier (50, 51, 53) . They further note the resultant limitations imposed by these biologic differences on the generalized use of biomarker prognostication (51) . Yet, our acute deterioration threshold criteria were equally valid in predicting late death. These data underscore a notable advantage of our real-time model: a high capacity for prognosticating decompensation and death independent of time after the initial insult. By contrast to a single or even repeated blood sampling that is predicated upon choosing a priori a specific time(s), our model is continuously "sampling" each animal and thus is more dependent upon each host's unique response to sepsis. In this vein, we believe that many of the animals miscategorized as "survivor" using the cytokine/biomarker threshold, but which ultimately died, would be accurately identified as "nonsurvivor" using biotelemetry methodology.
Other groups have developed and validated scoring systems for use in murine models of sepsis, usually based on a combination of behavioral and physical observations (23, 55, 56) . Although these scoring systems are able to separate mice that are significantly ill from sepsis from those that have a lesser sick response, they lack sensitivity in determining the exact point of physiologic deterioration. The resolution of these scoring systems is dependent on the frequency of mouse analysis and scoring, which requires handling or manipulation of the mouse and introduces bias from an animal's fear or escape responses (40) . Furthermore, scoring systems require a significant amount of experience with the grading scale to maintain consistency in scoring between individual laboratory personnel and minimize subjectivity. In addition, activity and behavior of mice in pain from surgery are similar to those of mice that are becoming septic, making judgment of mouse behavior in the postoperative period of a surgical model of sepsis difficult. Thus, we perceive our model to be more objective and less biased in quantifying and qualifying an individual mouse's response to sepsis.
There are several limitations to our study. Our threshold definitions were initially chosen using face validity and further tested for construct validity. Though we observed significant separation at the threshold for acute deterioration, alternative thresholds are possible-particularly those that identify earlier time points in the host response. However, having characterized the physiology of the murine response, one can now model a variety of thresholds representing various points along the host septic response. We propose that the defined deterioration thresholds herein serve as an experimental analog to human patients calling for emergency assistance: the murine "9-1-1." It is at this moment a subject may also be screened for trial inclusion. As a primary objective was to develop a testable murine model better resembling human clinical trial design, we specifically chose to not include routine antibiotic administration. It was perceived that the absence of antibiotics more closely parallels the natural course of human sepsis, which initially proceeds without antibiotic treatment until sufficient physiologic derangement has occurred to prompt the patient to seek medical care. We studied mice aged 8 to 12 weeks, a relatively young cohort, and we acknowledge that the host response to CLP is different in older mice (9, 57) . The use of a single strain and gender of mice represents an additional limitation although plans are being developed to expand this analysis to female mice and to add additional commonly used strains. Finally, we cannot rule out an inflammatory reaction to the biotelemetry device. However, in our control CLP mice, there was only a modest increase in baseline values.
CONCLUSIONS
In summary, a CLP murine model of sepsis coupled with implantable biotelemetry can identify the variability in the host response to sepsis and time of acute physiologic deterioration with adequate construct validity. This new approach avoids administering treatments to mice that do not become ill or suffer only mild physiologic changes at fixed time points used in prior models. It is anticipated that this model can serve as a platform for investigation of novel therapeutics in sepsis administered in a manner more analogous to the conduct of human trials.
